Bills Search Results

Search all bills

Keyword(s)

Help icon Using the Bill Introduced date fields will allow you to search bills by the date they were introduced into Parliament.
Clicking the 'Bill Introduced (From)' and 'Bill Introduced (To)' fields displays a calendar.
Alternatively select date by typing into these fields in the format 'dd/mm/yyyy'.

Help icon Using the Bill Progress date fields will allow you to search bills by the dates they progressed through Parliament.
Clicking the 'Bill Progress (From)' and 'Bill Progress (To)' fields displays a calendar.
Alternatively select date by typing into these fields in the format 'dd/mm/yyyy'.

Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 394

Sort

  • National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2010

    Track (What's this?)

    Date
    02 Jun 2010 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health and Ageing 
    Summary
    Amends the:
    National Health Act 1953
    in relation to: pricing arrangements for certain medicines listed on the Pharmaceutical Benefits Scheme; price disclosure arrangements; and the collection of under co-payment data; and
    Health Insurance Act 1973
    and
    Medicare Australia Act 1973
    to make consequential amendments. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2012

    Track (What's this?)

    Date
    23 May 2012 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    National Health Act 1953
    to: provide for prices for medicines supplied under the Pharmaceutical Benefits Scheme (PBS) to be expressed uniformly across different programs based on one ex-manufacturer price for all brands of a pharmaceutical item; provide for this uniform price to be used to set prices for different quantities of a pharmaceutical item and to calculate price changes, patient charges and price disclosure reductions; and make technical amendments in relation to listing PBS medicines for supply only through PBS prescriber bags. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits Transparency and Cost Recovery) Bill 2021

    Track (What's this?)

    Date
    17 Mar 2021 
    Chamber
    Senate 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: establish the statutory authority for the publication of information in relation to the Pharmaceutical Benefits Advisory Committee, including meeting agendas, meeting outcomes, public summary documents and information published on the Medicine Status Website; and provide for cost recovery arrangements, including specifying fees for services and costs incurred to be set out in a disallowable legislative instrument, replacing the existing regulations; and make consequential amendments. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2007

    Track (What's this?)

    Date
    15 Aug 2007 
    Chamber
    Senate 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    Health Insurance Act 1973
    and
    National Health Act 1953
    to allow authorised optometrists to prescribe certain ophthalmic (eye) medicines for supply under the Pharmaceutical Benefits Scheme. Also amends the
    National Health Act 1953
    to clarify the supply of pharmaceutical benefits ‘at or from’ approved premises. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2014

    Track (What's this?)

    Date
    18 Jun 2014 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    in relation to the Pharmaceutical Benefits Scheme and the Repatriation Pharmaceutical Benefits Scheme by: increasing the concessional patient co-payment by 80 cents from 1 January 2015; increasing the general patient co-payment by $5.00 from 1 January 2015; increasing the concessional safety net threshold by two prescriptions each year for four years, from 2015 to 2018; and increasing the general patient safety net threshold by 10 per cent each year for four years, from 2015 to 2018. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2015

    Track (What's this?)

    Date
    27 May 2015 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to implement the Pharmaceutical Benefits Scheme (PBS) Access and Sustainability package by: applying a one-off five per cent statutory price reduction for single brand medicines; changing price disclosure arrangements for multiple-brand medicines; applying flow-on price disclosure reductions from component drugs to multiple-brand combination medicines; changing membership arrangements for the Pharmaceutical Benefits Advisory Committee; enabling approved pharmacists to discount patient co-payments by a maximum of $1 for each PBS supply on a prescription; extending safety net early supply rules; and extending the pharmacy location rules and the role of the Australian Community Pharmacy Authority to 30 June 2020. Also makes technical amendments. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2016

    Track (What's this?)

    Date
    24 Nov 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: enable the minister, the secretary or the Chief Executive Medicare to arrange for the use of computer programs to make decisions and determinations, exercise powers or comply with obligations and do anything else related to those actions; enable approved pharmacists whose premises have been affected by disaster or exceptional circumstances to supply pharmaceutical benefits at alternative premises in the same locality for a limited period and be paid for claims at the full rate; and ensure that entitlements for concessional beneficiaries and their dependants will apply for pharmaceutical benefits until midnight on the day of a person’s death. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2019

    Track (What's this?)

    Date
    04 Jul 2019 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: introduce a fee for applications by pharmacists for approval to supply Pharmaceutical Benefits Scheme medicines at particular premises; and enable pharmaceutical benefits to continue temporarily to be supplied following bankruptcy or where there is an external administrator in relation to the pharmacy. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits) Bill 2019

    Track (What's this?)

    Date
    14 Feb 2019 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: introduce a fee for applications by pharmacists for approval to supply Pharmaceutical Benefits Scheme medicines at particular premises; and enable pharmaceutical benefits to continue temporarily to be supplied following bankruptcy or where there is an external administrator in relation to the pharmacy. 

    Bill | Explanatory Memorandum

  • National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Bill 2017

    Track (What's this?)

    Date
    18 Oct 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: increase the current statutory price reduction that applies when the first new brand of an existing pharmaceutical item is listed on the Pharmaceutical Benefits Scheme (PBS); extend and introduce statutory price reductions applying on certain anniversaries of an F1 formulary drug being listed on the PBS; introduce ministerial discretion in relation to the application of statutory price reductions in certain circumstances; make minor amendments to price disclosure arrangements; provide new circumstances whereby a new presentation of a brand of pharmaceutical item may be listed without being subject to a new brand statutory price reduction; continue the operation of the Australian Community Pharmacy Authority and the pharmacy location rules beyond 30 June 2020; and make technical amendments. 

    Bill | Explanatory Memorandum

Senator/Member search

Browse all Senators and Members